Methallylescaline
From Wikipedia, the free encyclopedia
![]() |
This article includes a list of references, related reading or external links, but its sources remain unclear because it lacks inline citations. (June 2013) (Learn how and when to remove this template message) |
![]() |
|
Names | |
---|---|
IUPAC name
2-{3,5-dimethoxy-4-[(2-methylprop-2-en-1-yl)oxy]phenyl}ethanamine
|
|
Identifiers | |
3D model (Jmol)
|
|
ChemSpider | |
|
|
|
|
Properties | |
C14H21NO3 | |
Molar mass | 251.321 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
![]() ![]() ![]() |
|
Infobox references | |
Methallylescaline, or 4-methallyloxy-3,5-dimethoxyphenethylamine, is a lesser-known psychedelic drug. It is also the 4-methyl analog of allylescaline. Methallylescaline was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the dosage range is listed as 40–65 mg, and the duration listed as 12–16 hours. Methallylescaline produces intense open and closed-eye visuals, such as neon colors and kaleidoscope-like imagery. Very little data exists about the pharmacological properties, metabolism, and toxicity of methallylescaline.
Legal status[edit]
Allylescaline is illegal in Sweden as of 26 January 2016.[1]
See also[edit]
References[edit]
- ^ "31 nya ämnen kan klassas som narkotika eller hälsofarlig vara" (in Swedish). Folkhälsomyndigheten. November 2015.
External links[edit]
![]() |
This psychoactive drug-related article is a stub. You can help Wikipedia by expanding it. |